Form EFFECT Evoke Pharma Inc
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 18, 2025 |
| Accession Number: | 0001193125-25-322685 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy-Back Programme
- MissionIRNewsBreaks – WhiteFiber, Inc. (NASDAQ: WYFI) Closes Upsized $310 Million Convertible Notes Offering
- Best’s Commentary: Nepal’s Catastrophic Floods Pressure a Thinly Insured Market
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
